Illinois State Senate District 21 issued the following announcement on Oct. 29.
State Senator Laura Ellman (D-Naperville) voted today in favor of legislation that would cap the skyrocketing cost of insulin.
“For those with diabetes, prescription insulin isn’t optional,” Ellman said. “People should not be forced to make a choice between their food or housing and medicine they need to inject to keep from dying. Increasing affordability so these choices don’t have to be made is the right thing to do.”
Senate Bill 667 would cap out-of-pocket insulin expenses at $100 for a 30-day supply for those who receive health insurance from the state.
Ellman said the legislation is also intended to spark a national conversation about skyrocketing insulin prices at a time when the American Diabetes Association says there are over 30 million Americans who have diabetes, 7.4 million of which require prescription insulin every day to survive. However, the increasing costs associated with the medication have led many patients to ration their supply or seek care outside of the country.
The legislation would make Illinois just the second state in the country to cap out-of-pocket insulin expenses. Colorado became the first to do so earlier this year.
The measure has also garnered the support of several advocacy organizations, including the American Diabetes Association, Illinois Alliance for Retired Americans, Illinois State Medical Society, Illinois Pharmacists Association and AARP.
Original source can be found here.